BioCardia, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BioCardia, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2016 to Q2 2024.
  • BioCardia, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $184K, a 42% decline year-over-year.
  • BioCardia, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $823K, a 28.7% decline year-over-year.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.03M, a 12.9% decline from 2022.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.18M, a 28.8% decline from 2021.
  • BioCardia, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.66M, a 43.7% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $823K $184K -$133K -42% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $956K $204K -$74K -26.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.03M $184K -$96K -34.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $1.13M $251K -$29K -10.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.16M $317K +$13K +4.28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $1.14M $278K -$41K -12.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.18M $280K -$144K -34% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $1.33M $280K -$157K -35.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $1.48M $304K -$80K -20.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $1.56M $319K -$97K -23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $1.66M $424K -$195K -31.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 $1.86M $437K -$300K -40.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.16M $384K -$271K -41.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $2.43M $416K -$525K -55.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $2.95M $619K +$207K +50.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $2.75M $737K -$19K -2.51% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $2.76M $655K -$41K -5.89% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.81M $941K +$251K +36.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $412K -$279K -40.4% Jan 29, 2020 10-K 2022-03-29
Q3 2019 $2.83M $756K +$26K +3.56% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $2.81M $696K -$42K -5.69% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $2.85M $690K +$75K +12.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 $2.77M $691K -$17K -2.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-09
Q3 2018 $2.79M $730K +$29K +4.14% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 $2.76M $738K +$62K +9.17% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $2.7M $615K -$7K -1.13% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 $2.71M $708K -$89K -11.2% Oct 1, 2017 Dec 31, 2017 10-K 2020-04-09
Q3 2017 $2.8M $701K +$614K +706% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.18M $676K +$648K +2314% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $1.53M $622K +$592K +1973% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $942K $797K Oct 1, 2016 Dec 31, 2016 10-K 2019-04-02
Q3 2016 $87K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $28K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $30K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.